Asensus Surgical Inc (ASXC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,777 | -144,796 | -119,980 | -46,948 | -37,652 |
| Depreciation Amortization | 13,662 | 10,854 | 70,870 | 3,575 | 1,393 |
| Income taxes - deferred | -3,377 | -3,300 | -5,562 | -1,024 | N/A |
| Accounts receivable | -7,225 | -381 | -1,041 | 133 | 55 |
| Accounts payable and accrued liabilities | 767 | -531 | -356 | 1,096 | -36 |
| Other Working Capital | -5,915 | -4,037 | -8,466 | 2,693 | 980 |
| Other Operating Activity | 15,372 | 94,896 | 12,149 | 1,716 | 1,907 |
| Operating Cash Flow | $-48,493 | $-47,295 | $-52,386 | $-38,759 | $-33,353 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -51,439 | N/A | N/A | N/A | N/A |
| PPE Investments | 3,758 | 5,934 | -1,361 | -1,234 | -2,149 |
| Net Acquisitions | -5,800 | N/A | N/A | -25,000 | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 6,191 |
| Purchase Sale Intangibles | N/A | -425 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -425 | 0 | 0 | 0 |
| Investing Cash Flow | $-53,481 | $5,509 | $-1,361 | $-26,234 | $4,042 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,507 | 13,005 | N/A | 9,887 | 4,291 |
| Debt Repayment | -15,305 | -13,343 | -6,902 | N/A | -2,877 |
| Common Stock Issued | 15,682 | 112,058 | 58,195 | 58,590 | 52,524 |
| Other Financing Activity | -2,432 | -7,349 | -1,350 | -73 | 0 |
| Financing Cash Flow | $26,452 | $104,371 | $49,943 | $68,404 | $53,938 |
| Exchange Rate Effect | -433 | 431 | -55 | 22 | N/A |
| Beginning Cash Position | 97,606 | 34,590 | 38,449 | 35,016 | 10,389 |
| End Cash Position | 21,651 | 97,606 | 34,590 | 38,449 | 35,016 |
| Net Cash Flow | $-75,955 | $63,016 | $-3,859 | $3,433 | $24,627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,493 | -47,295 | -52,386 | -38,759 | -33,353 |
| Capital Expenditure | -770 | -1,566 | -1,361 | -1,234 | -2,174 |
| Free Cash Flow | -49,263 | -48,861 | -53,747 | -39,993 | -35,527 |